Difficulty: Medium
Average Score: 73%
Practice
A nurse cares for four patients who are receiving clozapine lithium fluoxetine and venlafaxine respectively. With which patient should the nurse be most alert for problems associated with fluid and electrolyte imbalance?
Correct answer
A
Rationale
In this scenario, the nurse should be most alert for problems associated with fluid and electrolyte imbalance in the patient receiving lithium (option A). Lithium is known to cause disturbances in electrolyte levels, particularly sodium levels, which can lead to serious complications if not monitored closely.
Clozapine (option B) is associated with a risk of agranulocytosis and myocarditis, not fluid and electrolyte imbalances. Fluoxetine (option C) and venlafaxine (option D) are selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), respectively, which are not typically linked to significant fluid and electrolyte disturbances.
Understanding the side effects and monitoring requirements of psychotropic medications is crucial for nurses caring for patients with mental health conditions. Recognizing the specific risks associated with each medication helps ensure patient safety and wellbeing. Regular monitoring of electrolyte levels, especially in patients on lithium therapy, is essential to prevent adverse effects and provide optimal care.
Clozapine (option B) is associated with a risk of agranulocytosis and myocarditis, not fluid and electrolyte imbalances. Fluoxetine (option C) and venlafaxine (option D) are selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), respectively, which are not typically linked to significant fluid and electrolyte disturbances.
Understanding the side effects and monitoring requirements of psychotropic medications is crucial for nurses caring for patients with mental health conditions. Recognizing the specific risks associated with each medication helps ensure patient safety and wellbeing. Regular monitoring of electrolyte levels, especially in patients on lithium therapy, is essential to prevent adverse effects and provide optimal care.